Bausch + Lomb Corporation (BLCO)
NYSE: BLCO
· Real-Time Price · USD
12.34
-0.10 (-0.80%)
At close: Jun 13, 2025, 3:59 PM
12.09
-1.99%
After-hours: Jun 13, 2025, 05:05 PM EDT
-0.80% (1D)
| Bid | 11.67 |
| Market Cap | 4.36B |
| Revenue (ttm) | 4.83B |
| Net Income (ttm) | -490M |
| EPS (ttm) | -1.02 |
| PE Ratio (ttm) | -12.09 |
| Forward PE | 16.26 |
| Analyst | Hold |
| Ask | 12.99 |
| Volume | 849,323 |
| Avg. Volume (20D) | 855,596 |
| Open | 12.21 |
| Previous Close | 12.44 |
| Day's Range | 12.18 - 12.51 |
| 52-Week Range | 10.45 - 21.69 |
| Beta | 0.56 |
About BLCO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BLCO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BLCO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-15.74%
Bausch + Lomb shares are trading lower after the c...
Unlock content with
Pro Subscription
4 months ago
-9.52%
Bausch + Lomb shares are trading lower after the company announced that the process of going private will not result in a transaction at this time. Also, the company announced that the process to complete a full separation did not lead to an offer that reflected its value.
3 weeks ago · businesswire.com
Bausch + Lomb Announces 2025 Annual Meeting of Shareholders ResultsVAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live bet...